Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts

Molecular Nutrition and Food Research

Volumn 54, Issue 8, 2010, Pages 1192-1201

  Perry, Marie Claude ^a   Demeule, Michel ^a   Régina, Anthony ^a   Moumdjian, Robert ^b   Béliveau, Richard ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

Anti angiogenic; Anti tumor; Blood brain barrier; Curcumin; Glioblastoma

Indexed keywords

ANIMALIA; MUS; MUS MUSCULUS;

EID: 77953358276     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900277     Document Type: Article

References (27)

1. Grossman, S. A., Batara, J. F., Current management of glioblastoma multiforme. Semin. Oncol. 2004, 31, 635-644.
2. Chintala, S. K., Tonn, J. C., Rao, J. S., Matrix metalloproteinases and their biological function in human gliomas. Int. J. Dev. Neurosci. 1999, 17, 495-502.
3. Maheshwari, R. K., Singh, A. K., Gaddipati, J., Srimal, R. C., Multiple biological activities of curcumin: a short review. Life Sci. 2006, 78, 2081-2087.
4. Duvoix, A., Blasius, R., Delhalle, S., Schnekenburger, M. et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005, 223, 181-190.
5. Arbiser, J. L., Klauber, N., Rohan, R., van Leeuwen, R. et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol. Med. 1998, 4, 376-383.
6. Kesari, S., Ramakrishna, N., Sauvageot, C., Stiles, C. D., Wen, P. Y., Targeted molecular therapy of malignant gliomas. Curr. Neurol. Neurosci. Rep. 2005, 5, 186-197.
7. Leon, S. P., Folkerth, R. D., Black, P. M., Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996, 77, 362-372.
8. Bian, X. W., Du, L. L., Shi, J. Q., Cheng, Y. S., Liu, F. X., Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas. Anal. Quant. Cytol. Histol. 2000, 22, 267-274.
9. Cecchelli, R., Dehouck, B., Descamps, L., Fenart, L. et al. In vitro model for evaluating drug transport across the blood-brain barrier. Adv. Drug Deliv. Rev. 1999, 36, 165-178.
10. Silver, F. H., Trelstad, R. L., Type I collagen in solution. Structure and properties of fibril fragments. J. Biol. Chem. 1980, 255, 9427-9433.
11. Hendriks, H. R., Langdon, S., Berger, D. P., Breistol, K. et al. Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts. Eur. J. Cancer 1992, 28A, 767-773.
12. el Hafny, B., Bourre, J. M., Roux, F., Synergistic stimulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities by retinoic acid and astroglial factors in immortalized rat brain microvessel endothelial cells. J. Cell Physiol. 1996, 167, 451-460.
13. Demeule, M., Brossard, M., Page, M., Gingras, D., Beliveau, R., Matrix metalloproteinase inhibition by green tea catechins. Biochim. Biophys. Acta 2000, 1478, 51-60.
14. McMahon, G. A., Petitclerc, E., Stefansson, S., Smith, E. et al. Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J. Biol. Chem. 2001, 276, 33964-33968.
15. de Vries, N. A., Beijnen, J. H., Boogerd, W., van Tellingen, O., Blood-brain barrier and chemotherapeutic treatment of brain tumors. Exp. Rev. Neurother. 2006, 6, 1199-1209.
16. Lamy, S., Blanchette, M., Michaud-Levesque, J., Lafleur, R. et al. Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation. Carcinogenesis 2006, 27, 989-996.
17. Steward, W. P., Gescher, A. J., Curcumin in cancer management: recent results of analogue design and clinical studies and desirable future research. Mol. Nutr. Food Res. 2008, 52, 1005-1009.
18. Elattar, T. M., Virji, A. S., The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res. 2000, 20, 1733-1738.
19. Hong, R. L., Spohn, W. H., Hung, M. C., Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. Clin. Cancer Res. 1999, 5, 1884-1891.
20. Martin-Cordero, C., Lopez-Lazaro, M., Galvez, M., Ayuso, M. J., Curcumin as a DNA topoisomerase II poison. J. Enzyme Inhib. Med. Chem. 2003, 18, 505-509.
21. Zhang, J., Qi, H., Wu, C., [Research of anti-proliferation of curcumin on A549 human lung cancer cells and its mechanism]. Zhong Yao Cai 2004, 27, 923-927.
22. Vacca, A., Ribatti, D., Pellegrino, A., Dammacco, F., [Angiogenesis and anti-angiogenesis in human neoplasms. Recent developments and the therapeutic prospects]. Ann. Ital. Med. Int. 2000, 15, 7-19.
23. Pan, M. H., Huang, T. M., Lin, J. K., Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab. Dispos. 1999, 27, 486-494.
24. Cheng, A. L., Hsu, C. H., Lin, J. K., Hsu, M. M. et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21, 2895-2900.
25. Sawaya, R., Go, Y., Kyritisis, A. P., Uhm, J. et al. Elevated levels of Mr 92,000 type IV collagenase during tumor growth in vivo. Biochem. Biophys. Res. Commun. 1998, 251, 632-636.
26. Woo, M. S., Jung, S. H., Kim, S. Y., Hyun, J. W. et al. Curcumin suppresses phorbol ester-induced matrix metalloproteinase- 9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem. Biophys. Res. Commun. 2005, 335, 1017-1025.
27. Sharma, R. A., Gescher, A. J., Steward, W. P., Curcumin: the story so far. Eur. J. Cancer 2005, 41, 1955-1968.